Lutfi Kirdar Kartal Research Hospital, Istanbul
Estradiol valerate and dionegest therapy did not increase serum homocysteine levels
Published in Hospital Business Week, January 8th, 2006
According to a study from Turkey, "Several studies have verified that hormone replacement therapy (HRT) has protective effects on postmenopausal women's cardiovascular condition. However, highly significant recent studies have reported that women treated with HRT have more cardiovascular events than untreated women."
"An elevated homocysteine level is one important risk factor for cardiovascular disease (CVD)," asserted Z.M. Pirimoglu and colleagues. "As a good indicator of CVD risk, we examined the changes in plasma homocysteine...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
More Articles from Hospital Business Week
- CHF Solutions, Inc.
Data show benefits of Aquapheresis therapy in treating heart failure patients with fluid overload - Collaborations
Alliance formed with Allscripts to provide electronic prescribing solutions - Columbia University
Patients with Alzheimer disease receive less treatment for breast cancer than do other female Medicare beneficiaries - Healthcare Coverage
Arcadian Health plan improves coverage, expands to Arkansas - Medicare
Group comments on value of Medicare drug benefits program - Medicare
Kaiser, Council on Aging mount campaign to identify qualified Medicare beneficiaries - More from this issue of Hospital Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
